| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 06/25/2008 | EP1935415A2 Treatment of androgen-deprivation induced osteoporosis |
| 06/25/2008 | EP1934388A1 Method of drug design |
| 06/25/2008 | EP1934241A2 Novel series of imidazolyl substituted steroidal and indan-1-one derivatives |
| 06/25/2008 | EP1933831A2 Modulators of atp-binding cassette transporters |
| 06/25/2008 | EP1730127B1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 06/25/2008 | EP1395604B1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 06/25/2008 | EP1351683B1 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser |
| 06/25/2008 | EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 06/25/2008 | EP1261320B1 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396283C Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390923 novel non-steroidal propionanilide structured compounds; useful in hormonal therapy, male hypogonadism, andropause; 3-(4-Acetylamino-3-fluorophenoxy)-2-hydroxy-2-methyl-N-(3-methyl-4-nitrophenyl)propionamide; good water solubility; beneficial androgenic effects without harmful stimulation of prostate |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390668 Halogenated xanthan compound |
| 06/24/2008 | US7390625 Apoptosis-associated protein and use thereof |
| 06/24/2008 | US7390519 Probiotic Lactobacillus salivarius strains |
| 06/19/2008 | WO2008073956A2 Cyclic sulfonamide derivatives and methods of their use |
| 06/19/2008 | US20080145410 An iron-containing complex to treat hyperphosphatemia by adsorbing excess phosphates in the blood; capacity of >140 mg adsorbed phosphate by 1 g complex of an insoluble carbohydrate (starch), polynuclear iron oxide/hydroxide and a soluble glucose; stability; packaging; industrial scale |
| 06/19/2008 | DE102006058209A1 New triterpene type compounds comprising a pentacyclic basic unit of nor-oleanane- or nor-ursane-type, are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent diabetes, depression and glaucoma |
| 06/19/2008 | DE102006058207A1 New triterpene type compounds comprising a pentacyclic basic structure of nor-oleanan- or non-ursan -types are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent the diabetes, depression and glaucoma |
| 06/18/2008 | EP1931654A2 Modulators of metabolism and the treatment of disorders related thereto |
| 06/18/2008 | EP1931633A2 Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors |
| 06/18/2008 | EP1585521B1 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 06/18/2008 | EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 06/18/2008 | CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone |
| 06/18/2008 | CN101199647A Medicament compound agent for treating II model diabetes and reversing insulin resistive and preparing method thereof |
| 06/18/2008 | CN100395259C Steroid derivatives |
| 06/17/2008 | US7388006 Non-steroidal progesting |
| 06/17/2008 | US7387791 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 06/17/2008 | US7387776 Human monoclonal antibodies against CD30 |
| 06/17/2008 | CA2224269C Compressed dry-granulation desogestrel tablets |
| 06/12/2008 | WO2008067892A1 Sulphamate benzothiophene derivatives |
| 06/12/2008 | WO2008067710A1 Substituted cyclohexane compounds, preparation methods and medicine uses thereof |
| 06/12/2008 | WO2008067709A1 Substituted cyclobutane compounds, preparation methods and pharmaceutical uses thereof |
| 06/12/2008 | WO2008016768A8 Phytoestrogenic formulations and uses thereof |
| 06/12/2008 | US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
| 06/12/2008 | US20080139551 4-(4-methyl-piperazin-1-yl)-2-oxo-1-phenyl-1,2-dihydro-quinoline-3-carboxylic acid ethyl ester; anticarcinogenic, antiinflammatory agent; septic shock, respiratory distress syndrome, rheumatoid arthritis, osteoarthritis, asthma, autoimmune disorder, diabetes, multiple sclerosis, Cushing's disease |
| 06/12/2008 | US20080139530 7-Aryl 1,5-Dihydro-4,1-Benzoxazepin-2(3H)-One Derivatives And Their Use As Progesterone Receptor Modulators |
| 06/12/2008 | US20080138426 Remedies for sex hormone dependent disease |
| 06/12/2008 | CA2671990A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/12/2008 | CA2671311A1 Sulfamatobenzothiophene derivatives |
| 06/11/2008 | EP1930320A1 Novel fused pyrrole derivative |
| 06/11/2008 | EP1930000A1 Combination of organic compounds |
| 06/11/2008 | EP1928894A1 Novel c18 modified retrosteroids as progesterone receptor modulator compounds |
| 06/11/2008 | EP1420769B1 Lipid profile modulation with steroids and ppar alpha agonists |
| 06/11/2008 | EP1165113B1 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 06/11/2008 | CN101198618A Steroids having a mixed androgenic and progestagenic profile |
| 06/10/2008 | US7385032 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 06/10/2008 | US7385026 Modified ghrelin polypeptides |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7384967 Aryl carbonyl derivatives as therapeutic agents |
| 06/10/2008 | US7384651 Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience |
| 06/10/2008 | US7384418 Methods and devices for delivery of agents to breast milk ducts |
| 06/05/2008 | WO2008066494A1 THERAPEUTIC USES OF β-ANTAGONISTS |
| 06/05/2008 | WO2008066483A1 Use of nalp5 in methods for diagnosis and therapy of parathyroid related disorders |
| 06/05/2008 | WO2008066117A1 Cyclic amine compound |
| 06/05/2008 | WO2008066064A1 Regulation of the activity of transcriptional factor stat by zinc ion |
| 06/05/2008 | WO2008065508A1 Spiroketone acetyl-coa carboxylase inhibitors |
| 06/05/2008 | WO2008065100A1 Substituted estratrien derivatives as 17beta hsd inhibitors |
| 06/05/2008 | WO2008035228A3 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof |
| 06/05/2008 | WO2008024027A3 Use of 9-oxoacridine-10-acetic acid, its salts and esters for enhancing the efficacy of antiandrogenic treatment |
| 06/05/2008 | US20080132704 3-Substituted quinuclidines and their use |
| 06/05/2008 | US20080132476 Administering e.g. 17beta-Fluoro-9alpha-vinyl-estra-1,3,5(10)-triene-3,16alpha-diol to treat endometriosis, osteoporosis, or hormone replacement therapy in combination with other drugs |
| 06/05/2008 | US20080131494 Dermal Penetration enhancers and drug delivery systems involving same |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | DE10107186B4 Neue Form des PHGPx-Proteins als diagnostischer Marker bei männlicher Infertilität A new form of PHGPx protein as a diagnostic marker for male infertility |
| 06/05/2008 | CA2671075A1 Substituted estratrien derivatives as 17beta hsd inhibitors |
| 06/05/2008 | CA2670976A1 Cyclic amine compound |
| 06/04/2008 | EP1927352A2 Therapeutic methods and compositions involving isoflavones |
| 06/04/2008 | EP1648483B1 Composition for treating and/or preventing insulin resistance |
| 06/04/2008 | EP1474119B1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta |
| 06/04/2008 | EP1292607B1 Novel solid body forms of mesoprogestin 11beta- 4e-(hydroxyiminomethyl)-phenyl -17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-one |
| 06/04/2008 | CN100391972C Corticotropin releasing factor receptor 2 agonists |
| 06/04/2008 | CN100391944C Indoles useful in the treatment of androgen-receptor related diseases |
| 06/04/2008 | CN100391462C Enhanced drug delivery in transdermal systems |
| 06/03/2008 | US7381790 Copolymers for suppression of autoimmune diseases, and methods of use |
| 06/03/2008 | US7381718 new process for the preparation of a key intermediate |
| 06/03/2008 | US7381429 Hormone replacemnent therapy; menopause, osteoporosis, cardiovascular disorders; stroke; sexual disorders |
| 06/03/2008 | CA2467964C Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 05/29/2008 | WO2008064202A2 Modified-release formulations of calcium receptor-active compounds |
| 05/29/2008 | WO2008062830A1 Spiroquinone compound and pharmaceutical composition |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/28/2008 | EP1925617A1 Heterocyclic compound, and production process and use thereof |
| 05/28/2008 | EP1924580A1 Non-steroidal compounds useful as glucocorticoid receptor modulators |
| 05/28/2008 | EP1924256A1 Composition comprising a dendrimer and the use thereof for binding phosphate |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1343806B1 Methylene steroids as novel androgens |
| 05/28/2008 | EP1343483B1 Transdermal system containing a novel high potency progestagen |
| 05/28/2008 | EP1326630B1 Use of glp-2 peptides |
| 05/28/2008 | EP1313766B1 Coaster, a human coactivator of steroid receptors |
| 05/28/2008 | EP1246925B1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 05/28/2008 | CN101189251A 17 beta-HSD1 and STS inhibitors |
| 05/28/2008 | CN101189043A Use of adrenergic alpha2B antagonists for the treatment of vasomotor symptoms |
| 05/28/2008 | CN101189025A Stabilized parathyroid hormone composition comprising parathyroid hormone, buffer and stabilizing agent |
| 05/28/2008 | CN101186940A Process for obtaining insulin or insulin derivatives having correctly bonded cystine bridges |